Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 2,000 shares at $5.71 ($11K) on 2009-12-01, disclosed to the SEC on 2009-12-02.
Scheduled sale ($11k) by EVP & Chf, Research & Develop under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.63 | 100 | $563 | 4.9% |
| 2 | $5.65 | 100 | $565 | 5.0% |
| 3 | $5.66 | 200 | $1K | 9.9% |
| 4 | $5.68 | 300 | $2K | 15.0% |
| 5 | $5.69 | 200 | $1K | 10.0% |
| 6 | $5.70 | 282 |
| $2K |
| 14.1% |
| 7 | $5.71 | 200 | $1K | 10.0% |
| 8 | $5.72 | 300 | $2K | 15.1% |
| 9 | $5.73 | 100 | $573 | 5.0% |
| 10 | $5.74 | 50 | $287 | 2.5% |
| 11 | $5.76 | 168 | $968 | 8.5% |
| Total | $5.70 avg | 2,000 | $11K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |